How are JAK2 inhibitors administered?

How are JAK2 inhibitors administered?

JAK2 inhibitors are administered orally, and that's very convenient for the patients. So it's typically very easy for patients to utilize and receive the therapy. And it doesn't really have too much complications in terms of logistics for taking the JAK2 inhibitors. We have a large and diverse catchment area, so it would be difficult for these patients to drive 2 to 3 hours just to receive some type of cancer-directed therapy. So for us in myelofibrosis, we're really blessed in that most of these therapies are oral therapies.